🔗 Share this article

Texas Attorney General Ken Paxton is filing a lawsuit against the manufacturers of acetaminophen, claiming the firms concealed safety concerns that the medication presented to children's cognitive development.

The court filing follows a month after Donald Trump publicized an unsubstantiated connection between consuming acetaminophen - alternatively called acetaminophen - while pregnant and autism spectrum disorder in young ones.

Paxton is suing the pharmaceutical giant, which once produced the medication, the only pain reliever approved for women during pregnancy, and the current manufacturer, which presently makes it.

In a statement, he stated they "betrayed America by profiting off of pain and marketing drugs regardless of the potential hazards."

The company states there is no credible evidence connecting Tylenol to autism spectrum disorder.

"These manufacturers deceived for years, intentionally threatening millions to line their pockets," the attorney general, from the Republican party, declared.

The company said in a statement that it was "very worried by the spread of false claims on the security of acetaminophen and the potential impact that could have on the well-being of women and children in America."

On its official site, Kenvue also mentioned it had "consistently assessed the applicable studies and there is no credible data that demonstrates a established connection between taking paracetamol and autism spectrum disorder."

Groups representing medical professionals and healthcare providers share this view.

The American College of Obstetricians and Gynecologists has declared paracetamol - the primary component in Tylenol - is among limited choices for expectant mothers to address discomfort and fever, which can pose major wellness concerns if ignored.

"In multiple decades of investigation on the utilization of paracetamol in gestation, no reliable research has successfully concluded that the consumption of acetaminophen in any trimester of gestation causes brain development issues in offspring," the association stated.

This legal action cites current declarations from the previous government in asserting the medication is potentially dangerous.

In recent weeks, Trump caused concern from public health officials when he told women during pregnancy to "struggle intensely" not to take Tylenol when unwell.

The FDA then issued a notice that medical professionals should contemplate reducing the usage of Tylenol, while also mentioning that "a direct connection" between the drug and autism in young ones has not been proven.

Health Secretary Kennedy, who oversees the FDA, had vowed in April to conduct "comprehensive study program" that would determine the source of autism in a matter of months.

But authorities advised that finding a unique factor of autism spectrum disorder - considered by experts to be the result of a complex mix of genetic and surrounding conditions - would be difficult.

Autism is a form of permanent neurological difference and impairment that affects how people encounter and relate to the world, and is recognized using medical professional evaluations.

In his court filing, Paxton - who supports Trump who is campaigning for federal office - alleges Kenvue and J&J "deliberately disregarded and tried to quiet the evidence" around acetaminophen and autism.

This legal action attempts to require the firms "remove any marketing or advertising" that claims Tylenol is reliable for pregnant women.

The court case parallels the concerns of a group of guardians of minors with autism and ADHD who filed suit against the makers of acetaminophen in 2022.

A federal judge dismissed the lawsuit, declaring studies from the plaintiffs' authorities was inconclusive.